WestVac Biopharma Co., Ltd.
PrivateLast Round
Series C
Apr 21, 2022
Total Funding Raised
$45.41M
Company Overview
WestVac Biopharma Co., Ltd. operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series C round in April 2022.
WestVac Biopharma Co., Ltd. is a biotechnology company that focuses on the research, development, manufacturing, and commercialization of innovative vaccines and immunotherapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WestVac Biopharma Co., Ltd. Comparables
Compare WestVac Biopharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clover Biopharmaceuticals | 76% | |
| SK bioscience | 75% | |
| Cansino Biologics Inc. | 74% |
For institutional investors. Book with your work email.
WestVac Biopharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 21, 2022 | ||||
| VC Round | Aug 17, 2021 | ||||
| Series B | Apr 12, 2021 | ||||
| Series A | Nov 16, 2020 | ||||
| Angel | Sep 23, 2020 |
For institutional investors. Book with your work email.
WestVac Biopharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Hengtai Huasheng Asset Management | Series B |
| CDH Baifu | Series B |
| 中金浦成投资有限公司 | Series B |
| CICC Capital | Series C |
| CDH Investments | Series B |
| China Everbright Limited | VC Round |
| Haier Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2021
China Everbright Limited participated in the round.
- Nov 16, 2020
$45M round led by Shanghai Pharmaceuticals Holding Co Ltd
For institutional investors. Book with your work email.
WestVac Biopharma Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WestVac Biopharma Co., Ltd.'s valuation, stock price, and market status.
Is WestVac Biopharma Co., Ltd. a public or private company?
WestVac Biopharma Co., Ltd. is a private company.
What is the current stock price of WestVac Biopharma Co., Ltd.?
WestVac Biopharma Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks WestVac Biopharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WestVac Biopharma Co., Ltd. worth (valuation)?
Valuation information for WestVac Biopharma Co., Ltd. is not publicly available.
Can I buy WestVac Biopharma Co., Ltd. stock?
WestVac Biopharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WestVac Biopharma Co., Ltd.'s last funding round?
WestVac Biopharma Co., Ltd.'s most recent funding round was Series C on April 21, 2022.
Who are the main investors in WestVac Biopharma Co., Ltd.?
Key investors in WestVac Biopharma Co., Ltd. include Shenzhen Hengtai Huasheng Asset Management, CDH Baifu, 中金浦成投资有限公司, CICC Capital, CDH Investments.
Will WestVac Biopharma Co., Ltd. IPO soon?
No public IPO plans have been announced for WestVac Biopharma Co., Ltd..
How can I track WestVac Biopharma Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in WestVac Biopharma Co., Ltd.'s shares on secondary markets.